Therapeutic Drug Monitoring of Lacosamide by LC-MS/MS.

TitleTherapeutic Drug Monitoring of Lacosamide by LC-MS/MS.
Publication TypeJournal Article
Year of Publication2019
AuthorsYang HSarina, Edinboro L
JournalMethods Mol Biol
Volume1872
Pagination67-73
Date Published2019
ISSN1940-6029
KeywordsAnticonvulsants, Chromatography, Liquid, Data Interpretation, Statistical, Drug Monitoring, Humans, Lacosamide, Tandem Mass Spectrometry
Abstract

High-performance liquid chromatography tandem mass spectrometry (LC-MS/MS) has become a primary analytical methodology in therapeutic drug monitoring of antiepileptic drugs (AEDs). To demonstrate the utility of LC-MS/MS in measuring drug concentrations in serum or plasma, analysis of lacosamide (Vimpat) is discussed in this chapter. Lacosamide is an example of the newer-generation AEDs. The drug is extracted by protein precipitation and dilution of the serum specimen. A small volume of the extracted specimen is injected into a reversed-phase chromatography column, and lacosamide is identified by positive electrospray ionization (ESI) mass spectrometry in the multiple reaction monitoring (MRM) mode, which provides selectivity for quantitative analysis. A deuterated internal standard is used to correct for any loss of analyte during the process of extraction and analysis. A seven-point calibration curve and two levels of quality controls are included in each batch.

DOI10.1007/978-1-4939-8823-5_7
Alternate JournalMethods Mol Biol
PubMed ID30350280
Related Faculty: 
He Sarina Yang, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700